Exchange Traded Concepts LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.4% in the ...

Flagship Harbor Advisors LLC acquired a new stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a price target ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

However, the use of continuous glucose monitoring is on the rise and there is no study of the magnitude of the DCCT to affirm CGM-based metrics as standard for evaluating diabetes control," said Boris ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, Graz A-8010, Austria ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially ... s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor ...

"Dexcom made key strategic investments in 2024," said CEO Kevin Sayer, adding the company plans to build on these investments in 2025 by advocating for greater CGM access globally. The company is ...